Human Genome Epidemiology Literature Finder
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Esophageal Neoplasms and PIK3CA[original query] |
|---|
| Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. International journal of cancer 2006 May 118 (10): 2644-6. Phillips Wayne A, Russell Sarah E, Ciavarella Marianne L, Choong David Y H, Montgomery Karen G, Smith Katherine, Pearson Richard B, Thomas Robert J S, Campbell Ian |
| Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Feb 27 (6): 857-71. Hildebrandt Michelle A T, Yang Hushan, Hung Mien-Chie, Izzo Julie G, Huang Maosheng, Lin Jie, Ajani Jaffer A, Wu Xife |
| PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 May 19 (9): 2451-9. Shigaki Hironobu, Baba Yoshifumi, Watanabe Masayuki, Murata Asuka, Ishimoto Takatsugu, Iwatsuki Masaaki, Iwagami Shiro, Nosho Katsuhiko, Baba Hid |
| PIK3CA hypomethylation plays a key role in activation of the PI3K/AKT pathway in esophageal cancer in Chinese patients. Acta pharmacologica Sinica 2013 Dec 34 (12): 1560-7. Wang Wei-feng, Xie Yan, Zhou Zhi-hua, Qin Zheng-hong, Wu Jun-chao, He Jing-ka |
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
| Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients. Diagnostic pathology 2014 9 153. Ming Zizhen, Jiang Dongxian, Hu Qin, Li Xiaojing, Huang Jie, Xu Yifan, Liu Yalan, Xu Chen, Hua Xiuguo, Hou Yingyo |
| High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus. BMC cancer 2014 14 (1): 19. Zhang Zhimin, Xiao Hualiang, Xie Fei, Zhang Hui, Chen Chuan, Xiao He, Yang Zhenzhou, Wang Dong, Li Zengpeng, Wang |
| Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2015 Aug 123 (8): 639-47. Tasioudi Konstantia E, Sakellariou Stratigoula, Levidou Georgia, Theodorou Dimitrios, Michalopoulos Nikolaos V, Patsouris Efstratios, Korkolopoulou Penelope, Saetta Angelica |
| TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing. Cancer genomics & proteomics 0 13 (3): 231-8. Zheng Huili, Wang Yan, Tang Chuanning, Jones Lindsey, Ye Hua, Zhang Guangchun, Cao Weihai, Li Jingwen, Liu Lifeng, Liu Zhencong, Zhang Chao, Lou Feng, Liu Zhiyuan, Li Yangyang, Shi Zhenfen, Zhang Jingbo, Zhang Dandan, Sun Hong, Dong Haichao, Dong Zhishou, Guo Baishuai, Yan H E, Lu Qingyu, Huang Xue, Chen Si- |
| Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population. Gastroenterology 2016 05 150 (5): 1171-1182. Sawada Genta, Niida Atsushi, Uchi Ryutaro, Hirata Hidenari, Shimamura Teppei, Suzuki Yutaka, Shiraishi Yuichi, Chiba Kenichi, Imoto Seiya, Takahashi Yusuke, Iwaya Takeshi, Sudo Tomoya, Hayashi Tomoatsu, Takai Hiroki, Kawasaki Yoshihiro, Matsukawa Takashi, Eguchi Hidetoshi, Sugimachi Keishi, Tanaka Fumiaki, Suzuki Hiromichi, Yamamoto Ken, Ishii Hideshi, Shimizu Makiko, Yamazaki Hiroshi, Yamazaki Makoto, Tachimori Yuji, Kajiyama Yoshiaki, Natsugoe Shoji, Fujita Hiromasa, Mafune Kenichi, Tanaka Yoichi, Kelsell David P, Scott Claire A, Tsuji Shoji, Yachida Shinichi, Shibata Tatsuhiro, Sugano Sumio, Doki Yuichiro, Akiyama Tetsu, Aburatani Hiroyuki, Ogawa Seishi, Miyano Satoru, Mori Masaki, Mimori Kos |
| Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification. Oncotarget 2017 9 8 (31): 50832-50844. Ren Yongxin, Zheng Jianming, Fan Shiming, Wang Linfang, Cheng Min, Shi Dongxia, Zhang Wei, Tang Renxiang, Yu Ying, Jiao Longxian, Ni Jun, Yang Haibin, Cai Huaqing, Yin Fang, Chen Yunxin, Zhou Feng, Zhang Weihan, Qing Weiguo, Su Weig |
| Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Jul 35 (20): 2279-2287. Petty Russell D, Dahle-Smith Asa, Stevenson David A J, Osborne Aileen, Massie Doreen, Clark Caroline, Murray Graeme I, Dutton Susan J, Roberts Corran, Chong Irene Y, Mansoor Wasat, Thompson Joyce, Harrison Mark, Chatterjee Anirban, Falk Stephen J, Elyan Sean, Garcia-Alonso Angel, Fyfe David Walter, Wadsley Jonathan, Chau Ian, Ferry David R, Miedzybrodzka Zos |
| PI3K Overexpression and PIK3CA Mutations Are Associated with Age, Tumor Staging, and Other Clinical Characteristics in Chinese Patients with Esophageal Squamous Cell Carcinoma. Genetic testing and molecular biomarkers 2017 Apr 21 (4): 236-241. Lin Jing-Wei, Li Xu, Qiu Ming-Lian, Luo Rong-Gang, Lin Jian-Bo, Liu |
| PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue. BMC cancer 2018 8 18 (1): 826. Yokota Tomoya, Serizawa Masakuni, Hosokawa Ayumu, Kusafuka Kimihide, Mori Keita, Sugiyama Toshiro, Tsubosa Yasuhiro, Koh Yasuhi |
| PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome. Infectious agents and cancer 2019 1 13 43. Munari Fernanda Franco, Cruvinel-Carloni Adriana, Lacerda Croider Franco, de Oliveira Antônio Talvane Torres, Scapulatempo-Neto Cristovam, da Silva Sandra Regina Morini, Crema Eduardo, Adad Sheila Jorge, Rodrigues Maria Aparecida Marchesan, Henry Maria Aparecida Coelho Arruda, Guimarães Denise Peixoto, Longatto-Filho Adhemar, Reis Rui Manu |
| Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort. Frontiers in oncology 2020 9 10 1457. Mangalaparthi Kiran K, Patel Krishna, Khan Aafaque A, Manoharan Malini, Karunakaran Coral, Murugan Sakthivel, Gupta Ravi, Gupta Rohit, Khanna-Gupta Arati, Chaudhuri Amitabha, Kumar Prashant, Nair Bipin, Kumar Rekha V, Prasad T S Keshava, Chatterjee Aditi, Pandey Akhilesh, Gowda Hars |
| Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma. OncoTargets and therapy 2020 13 12797-12809. Zhang Nan, Shi Junping, Shi Xiaoliang, Chen Wenting, Liu Junfe |
| Exome sequencing identifies novel somatic variants in African American esophageal squamous cell carcinoma. Scientific reports 2021 Jul 11 (1): 14814. Erkizan Hayriye Verda, Sukhadia Shrey, Natarajan Thanemozhi G, Marino Gustavo, Notario Vicente, Lichy Jack H, Wadleigh Robert |
| Genetic analysis of rapidly progressing esophageal squamous cell carcinoma: A case report. Medicine 2021 3 100 (9): e24462. Zhao Shuang, Sun Ni, Yuan Xi, Shen Zetian, Zhu Xixu, Li Ji |
| Systematic Review and Meta-analysis of the Most Common Genetic Mutations in Esophageal Squamous Cell Carcinoma. Journal of gastrointestinal cancer 2021 Oct . Naseri Amirreza, Salehi-Pourmehr Hanieh, Majidazar Reza, Seraji Parya, Rezazadeh-Gavgani Erfan, Zehtabi Mojtaba, Kiani-Kezbin Hamed, Salehnia Fatemeh, Hassannezhad Sina, Hajikamanj Arash, Raeisi Morta |
| Profile of esophageal squamous cell carcinoma mutations in Brazilian patients. Scientific reports 2021 10 11 (1): 20596. Munari Fernanda Franco, Dos Santos Wellington, Evangelista Adriane Feijó, Carvalho Ana Carolina, Pastrez Paula Aguiar, Bugatti Diego, Wohnrath Durval R, Scapulatempo-Neto Cristovam, Guimarães Denise Peixoto, Longatto-Filho Adhemar, Reis Rui Manu |
| Genomic Profiling Identified Prognostic Biomarkers of Definitive Chemo-Radiotherapy Response in Esophageal Carcinoma. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): S13. Li L, Yuan S, Sun J, Yin Y, Cui J, Zhang J, Chen Y, Pang J, Yin J, Shao Y, Yu |
| An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma. Cancer cell 2023 4 . Chen Yan-Xing, Wang Zi-Xian, Jin Ying, Zhao Qi, Liu Ze-Xian, Zuo Zhi-Xiang, Ju Huai-Qiang, Cui Chengxu, Yao Jun, Zhang Yanqiao, Li Mengxia, Feng Jifeng, Tian Lin, Xia Xiao-Jun, Feng Hui, Yao Sheng, Wang Feng-Hua, Li Yu-Hong, Wang Feng, Xu Rui-H |
- Page last reviewed:Feb 1, 2024
- Content source: